Robert T. Davis, Jr

Executive Vice President, President, Tissue TechnologiesatIntegra Lifesciences Holdings· In proxies 2021–2025

Pay in FY2025-15% from the year before · Integra Lifesciences Holdings stock -45.2% the same year

Robert T. Davis, Jr was paid $1.9M in FY2025 (Dec), down 15%. Integra Lifesciences Holdings stock fell 45.2% that year.

Pay$100 in the stock at the end of FY20 → $19

Pay is from the Summary Compensation Table of each Integra Lifesciences Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

IART
Integra Lifesciences HoldingsPublic company · 5 yr
- Executive Vice President, President, Tissue Technologies2021 – Present · 5 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

Pay
Integra Lifesciences Holdings Division head pay fell 15% to $1.9M. The stock fell 45% in FY2025 (Dec).
DEF 14AApr 6, 2026
Pay
Integra Lifesciences Holdings Division head pay rose 59% to $2.3M. The stock fell 48% in FY2024 (Dec).
DEF 14AApr 4, 2025
Pay
Integra Lifesciences Holdings Division head pay fell 26% to $1.4M. The stock fell 22% in FY2023 (Dec).
DEF 14AApr 4, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?